AbbVie said it entered into a revolving credit agreement on January 30, 2025 with JPMorgan Chase Bank, N.A. as administrative agent, establishing an unsecured revolving credit facility of up to $3.0 billion.

1. 01

   AbbVie said it entered into a revolving credit agreement on January 30, 2025 with JPMorgan Chase Bank, N.A. as administrative agent, establishing an unsecured revolving credit facility of up to $3.0 billion.

2. 02

   The company said the credit facility matures on January 30, 2030. It added that the facility allows unsecured borrowing at variable interest rates and includes various covenants.

3. 03

   The company said there were no borrowings outstanding under the revolving credit agreement as of the effective date, January 30, 2025.

4. 04

   AbbVie said its existing $5.0 billion revolver, maturing in March 2028, remains in effect, so it has access to revolving credit facilities totaling $8.0 billion as of the effective date.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.